Senior Manager, Corporate Development and Strategy

Overview

Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA (tenapanor) and XPHOZAH (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL (tenapanor) for hyperphosphatemia in Japan.

A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada.

Reporting to the Director of Corporate Development and Strategy, the Senior Manager of Corporate Development and Strategy will have a direct impact on the strategic evolution of the company. This individual will have a key role in supporting the development and execution of Ardelyx s short- and long-term growth strategies. This individual will help to identify and assess assets for M&A and licensing, working closely with R&D functional leaders across Non-clinical, Clinical, CMC, and Regulatory.

We are looking for a highly motivated and organized professional who is passionate about making a positive impact on our business, our industry, and, ultimately, our patients.

• Search and Evaluation
• Support the Search and Evaluation function to proactively and systemically identify external opportunities aligned with Ardelyx s therapeutic area strategy, capabilities, and portfolio needs
• Conduct the scientific, clinical, and regulatory evaluation of external opportunities in partnership with nonclinical, clinical, and regulatory R&D functional leads
• Lead research with scientific/technical KOL experts to assess technology/platform across indications of interest & competitive pipeline
• Collaborate closely with Business Development lead to support business case development and execution planning
• Execute sourcing strategy for BD&L opportunities through proactive monitoring of the external innovation landscape including biotech, academic, and emerging companies to identify areas of strategic interest
• Read and monitor leading scientific journals (i.e., NEJM, Nature, Science) for emerging technologies, preclinical, and clinical stage assets to identify new BD&L opportunities
• Attend external partnering and scientific conferences and meetings

• PhD, MD, Pharm
  
  D or equivalent advanced degree in life sciences with 3+ years of experience in Search & Evaluation, Business Development, Strategy, or Corporate Development
• Strong verbal and written communication skills, with the ability to present complex data and insights clearly in effective, concise reports and presentations
• Ability to work independently in a fast-paced environment with strong attention to detail
• Collaborative style, with the ability to build and enhance partnership across the organization

• Waltham, MA or Newark, CA office-based

The anticipated annualized base pay range for this full-time position is $139,000-$169,000. Ardelyx utilizes industry data to ensure that our compensation is competitive and aligned with our industry peers. Actual base pay will be determined based on a variety of factors, including years of relevant experience, training, qualifications, and internal equity. The compensation package may also include an annual bonus target and equity awards, subject to eligibility and other requirements.

Ardelyx also offers a robust benefits package to employees, including a 401(k) plan with generous employer match, 12 weeks of paid parental leave, up to 12 weeks of living organ and bone marrow leave, equity incentive plans, health plans (medical, prescription drug, dental, and vision),life insurance and disability, flexible time off, annual Winter Holiday shut down, and at least 11 paid holidays.

Ardelyx is an equal opportunity employer.